- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 450838, 13 pages
Effects of Fructus mume Extract on MAPK and NF-κB Signaling and the Resultant Improvement in the Cognitive Deficits Induced by Chronic Cerebral Hypoperfusion
1Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 305-811, Republic of Korea
2Department of Biological Sciences, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea
3Department of Neurology, Konkuk University Hospital, Center for Geriatric Neuroscience Research, Institute of Biomedical Science and Technology, Konkuk University, Seoul 143-729, Republic of Korea
4College of Pharmacy, Chungbuk National University, Cheongju 361-763, Republic of Korea
Received 26 September 2012; Revised 26 November 2012; Accepted 3 December 2012
Academic Editor: Mohd Roslan Sulaiman
Copyright © 2012 Won Kyung Jeon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. F. Dubois and R. Hébert, “The incidence of vascular dementia in Canada: a comparison with Europe and East Asia,” Neuroepidemiology, vol. 20, no. 3, pp. 179–187, 2001.
- E. Farkas, P. G. M. Luiten, and F. Bari, “Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases,” Brain Research Reviews, vol. 54, no. 1, pp. 162–180, 2007.
- H. Akiyama, S. Barger, S. Barnum et al., “Inflammation and Alzheimer's disease,” Neurobiology of Aging, vol. 21, no. 3, pp. 383–421, 2000.
- H. Tomimoto, I. Akiguchi, H. Wakita, T. Suenaga, S. Nakamura, and J. Kimura, “Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer's disease patients,” Acta Neuropathologica, vol. 94, no. 2, pp. 146–152, 1997.
- I. Akiguchi, H. Tomimoto, T. Suenaga, H. Wakita, and H. Budka, “Alterations in glia and axons in the brains of Binswanger's disease patients,” Stroke, vol. 28, no. 7, pp. 1423–1429, 1997.
- G. A. Rosenberg, “Inflammation and white matter damage in vascular cognitive impairment,” Stroke, vol. 40, no. 3, pp. S20–S23, 2009.
- G. A. Rosenberg, N. Sullivan, and M. M. Esiri, “White matter damage is associated with matrix metalloproteinases in vascular dementia,” Stroke, vol. 32, no. 5, pp. 1162–1168, 2001.
- H. Tomimoto, M. Ihara, H. Wakita et al., “Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat,” Acta Neuropathologica, vol. 106, no. 6, pp. 527–534, 2003.
- M. Tsuchiya, K. Sako, S. Yura, and Y. Yonemasu, “Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats,” Experimental Brain Research, vol. 89, no. 1, pp. 87–92, 1992.
- H. Wakita, H. Tomimoto, I. Akiguchi, and J. Kimura, “Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia,” Brain Research, vol. 792, no. 1, pp. 105–113, 1998.
- H. Ohta, H. Nishikawa, H. Kimura, H. Anayama, and M. Miyamoto, “Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats,” Neuroscience, vol. 79, no. 4, pp. 1039–1050, 1997.
- T. Otori, T. Katsumata, H. Muramatsu, F. Kashiwagi, Y. Katayama, and A. Terashi, “Long-term measurement of cerebral blood flow and metabolism in a rat chronic hypoperfusion model,” Clinical and Experimental Pharmacology and Physiology, vol. 30, no. 4, pp. 266–272, 2003.
- H. Wakita, H. Tominoto, I. Akiguchi, and J. Kimura, “Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study,” Acta Neuropathologica, vol. 87, no. 5, pp. 484–492, 1994.
- J. J. Haddad, “Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention?” Progress in Neurobiology, vol. 73, no. 5, pp. 359–377, 2004.
- Y. K. Hwang, M. Jinhua, B.-R. Choi et al., “Effects of Scutellaria baicalensis on chronic cerebral hypoperfusion- induced memory impairments and chronic lipopolysaccharide infusion-induced memory impairments,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 681–689, 2011.
- B. R. Choi, K. J. Kwon, S. H. Park et al., “Alternations of septal-hippocampal system in the adult wistar rat with spatial memory impairments induced by chronic cerebral hypoperfusion,” Experimental Neurobiology, vol. 20, pp. 92–99, 2011.
- M. P. Mattson and M. K. Meffert, “Roles for NF-κB in nerve cell survival, plasticity, and disease,” Cell Death and Differentiation, vol. 13, no. 5, pp. 852–860, 2006.
- M. K. Meffert, J. M. Chang, B. J. Wiltgen, M. S. Fanselow, and D. Baltimore, “NF-κB functions in synaptic signaling and behavio,” Nature Neuroscience, vol. 6, pp. 1072–1078, 2003.
- B. Kaltschmidt, M. Uherek, B. Volk, P. A. Baeuerle, and C. Kaltschmidt, “Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 6, pp. 2642–2647, 1997.
- J. Liu, D. Z. Jin, L. Xiao, and X. Z. Zhu, “Paeoniflorin attenuates chronic cerebral hypoperfusion-induced learning dysfunction and brain damage in rats,” Brain Research, vol. 1089, no. 1, pp. 162–170, 2006.
- L. Liu, S. Yuan, Y. Sun et al., “The possible mechanisms of Fructus mume pill in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats,” Journal of Ethnopharmacology, vol. 126, no. 3, pp. 557–564, 2009.
- H. J. Choi, O. H. Kang, P. S. Park et al., “Mume Fructus water extract inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages,” Journal of Medicinal Food, vol. 10, no. 3, pp. 460–466, 2007.
- M. Gallagher, R. Burwell, and M. Burchinal, “Severity of spatial learning impairment in aging: development of a learning index for performance in the morris water maze,” Behavioral Neuroscience, vol. 107, no. 4, pp. 618–626, 1993.
- E. K. Murphy, R. L. Spencer, K. J. Sipe, and J. P. Herman, “Decrements in nuclear glucocorticoid receptor (GR) protein levels and DNA binding in aged rat hippocampus,” Endocrinology, vol. 143, no. 4, pp. 1362–1370, 2002.
- M. Adzic, J. Djordjevic, A. Djordjevic et al., “Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain,” Journal of Endocrinology, vol. 202, no. 1, pp. 87–97, 2009.
- Y. Imai, I. Ibata, D. Ito, K. Ohsawa, and S. Kohsaka, “A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage,” Biochemical and Biophysical Research Communications, vol. 224, no. 3, pp. 855–862, 1996.
- B.-R. Choi, S. R. Lee, J.-S. Han et al., “Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model,” Stroke, vol. 42, no. 9, pp. 2595–2604, 2011.
- Q. Jin, C. Lee, J. W. Lee et al., “Chemical constituents from the fruits of Prunus mume,” Natural Product Sciences, vol. 18, no. 3, pp. 200–203, 2012.
- U. V. Eitzen, R. Egensperger, S. Kösel et al., “Microglia and the development of spongiform change in Creutzfeldt-Jakob disease,” Journal of Neuropathology and Experimental Neurology, vol. 57, no. 3, pp. 246–256, 1998.
- B. R. Choi, S. R. Lee, J. S. Han et al., “Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model,” Stroke, vol. 42, pp. 2595–2604, 2011.
- J. David Sweatt, “The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory,” Journal of Neurochemistry, vol. 76, no. 1, pp. 1–10, 2001.
- H. A. Kwon, Y. J. Kwon, D. Y. Kwon, and J. H. Lee, “Evaluation of antibacterial effects of a combination of Coptidis Rhizoma, Mume Fructus, and Schizandrae Fructus against Salmonella,” International Journal of Food Microbiology, vol. 127, no. 1-2, pp. 180–183, 2008.
- H. Ina, K. Yamada, K. Matsumoto, and T. Miyazaki, “Inhibitory effects of benzyl glucoside and chlorogenic acid from Prunus mume on bradykinin and prostaglandin E2 production in the abdominal cavities of mice,” Natural Medicines, vol. 56, no. 5, pp. 184–186, 2002.
- M. D. dos Santos, M. C. Almeida, N. P. Lopes, and G. E. P. de Souza, “Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid,” Biological and Pharmaceutical Bulletin, vol. 29, no. 11, pp. 2236–2240, 2006.
- D. S. Jang, Y. M. Lee, I. H. Jeong, and J. S. Kim, “Constituents of the flowers of Platycodon grandiflorum with inhibitory activity on advanced glycation end products and rat lens aldose reductase in vitro,” Archives of Pharmacal Research, vol. 33, no. 6, pp. 875–880, 2010.
- E. Emanuele, A. D'Angelo, C. Tomaino et al., “Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia,” Archives of Neurology, vol. 62, no. 11, pp. 1734–1736, 2005.
- C. M. Atkins, J. C. Selcher, J. J. Petraitis, J. M. Trzaskos, and J. D. Sweatt, “The MAPK cascade is required for mammalian associative learning,” Nature Neuroscience, vol. 1, no. 7, pp. 602–609, 1998.
- J. C. Selcher, C. M. Atkins, J. M. Trzaskos, R. Paylor, and J. D. Sweatt, “A necessity for MAP kinase activation in mammalian spatial learning,” Learning and Memory, vol. 6, no. 5, pp. 478–490, 1999.